CLBCX
Price
$34.97
Change
+$0.21 (+0.60%)
Updated
Jan 17 closing price
Net Assets
240.18B
FBLAX
Price
$12.46
Change
+$0.04 (+0.32%)
Updated
Jan 17 closing price
Net Assets
3.4B
Ad is loading...

CLBCX vs FBLAX

Header iconCLBCX vs FBLAX Comparison
Open Charts CLBCX vs FBLAXBanner chart's image
American Funds American Balanced 529C
Price$34.97
Change+$0.21 (+0.60%)
VolumeN/A
Net Assets240.18B
Franklin Managed Income A
Price$12.46
Change+$0.04 (+0.32%)
VolumeN/A
Net Assets3.4B
CLBCX vs FBLAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. FBLAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and FBLAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 240B vs. FBLAX (3.4B). FBLAX pays higher dividends than CLBCX: FBLAX (4.45) vs CLBCX (1.52). CLBCX was incepted earlier than FBLAX: CLBCX (23 years) vs FBLAX (19 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. FBLAX (92.40). CLBCX has a lower initial minimum investment than FBLAX: CLBCX (250) vs FBLAX (1000). CLBCX annual gain was more profitable for investors over the last year : 11.42 vs. FBLAX (6.45). CLBCX return over 5 years is better than : 26.62 vs. FBLAX (17.06).
CLBCXFBLAXCLBCX / FBLAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years19 years-
Gain YTD1.8941.054180%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets240B3.4B7,051%
Annual Yield % from dividends1.524.4534%
Returns for 1 year11.426.45177%
Returns for 3 years11.243.71303%
Returns for 5 years26.6217.06156%
Returns for 10 years56.7837.72151%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROK286.605.64
+2.01%
Rockwell Automation
SANM82.970.41
+0.50%
Sanmina Corp
YMAB6.16-0.02
-0.32%
Y-mAbs Therapeutics
SABS3.53-0.03
-0.84%
SAB Biotherapeutics
ALEX17.55-0.16
-0.90%
Alexander & Baldwin